227 related articles for article (PubMed ID: 35269655)
1. Targeted Analysis of Sphingolipids in Turkeys Fed Fusariotoxins: First Evidence of Key Changes That Could Help Explain Their Relative Resistance to Fumonisin Toxicity.
Guerre P; Travel A; Tardieu D
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269655
[TBL] [Abstract][Full Text] [Related]
2. Targeted sphingolipid analysis in chickens suggests different mechanisms of fumonisin toxicity in kidney, lung, and brain.
Guerre P; Matard-Mann M; Nyvall Collén P
Food Chem Toxicol; 2022 Dec; 170():113467. PubMed ID: 36241089
[TBL] [Abstract][Full Text] [Related]
3. Fumonisins alone or mixed with other fusariotoxins increase the C22-24:C16 sphingolipid ratios in chicken livers, while deoxynivalenol and zearalenone have no effect.
Guerre P; Lassallette E; Beaujardin-Daurian U; Travel A
Chem Biol Interact; 2024 May; 395():111005. PubMed ID: 38615975
[TBL] [Abstract][Full Text] [Related]
4. Targeted Sphingolipid Analysis in Heart, Gizzard, and Breast Muscle in Chickens Reveals Possible New Target Organs of Fumonisins.
Guerre P; Gilleron C; Matard-Mann M; Nyvall Collén P
Toxins (Basel); 2022 Nov; 14(12):. PubMed ID: 36548725
[TBL] [Abstract][Full Text] [Related]
5. Targeted sphingolipidomics indicates increased C22-C24:16 ratios of virtually all assayed classes in liver, kidney, and plasma of fumonisin-fed chickens.
Lassallette E; Collén PN; Guerre P
Ecotoxicol Environ Saf; 2023 Dec; 268():115697. PubMed ID: 37979349
[TBL] [Abstract][Full Text] [Related]
6. Toxicity of Fumonisins, Deoxynivalenol, and Zearalenone Alone and in Combination in Turkeys Fed with the Maximum European Union-Tolerated Level.
Travel A; Metayer JP; Mika A; Bailly JD; Cleva D; Boissieu C; Le Guennec J; Albaric O; Labrut S; Lepivert G; Marengue E; Froment P; Tardieu D; Guerre P
Avian Dis; 2019 Dec; 63(4):703-712. PubMed ID: 31865686
[TBL] [Abstract][Full Text] [Related]
7. Fumonisin B1 inhibits sphingosine (sphinganine) N-acyltransferase and de novo sphingolipid biosynthesis in cultured neurons in situ.
Merrill AH; van Echten G; Wang E; Sandhoff K
J Biol Chem; 1993 Dec; 268(36):27299-306. PubMed ID: 8262970
[TBL] [Abstract][Full Text] [Related]
8. Disruption of sphingolipid metabolism and stimulation of DNA synthesis by fumonisin B1. A molecular mechanism for carcinogenesis associated with Fusarium moniliforme.
Schroeder JJ; Crane HM; Xia J; Liotta DC; Merrill AH
J Biol Chem; 1994 Feb; 269(5):3475-81. PubMed ID: 8106389
[TBL] [Abstract][Full Text] [Related]
9. Early fumonisin B1 toxicity in relation to disrupted sphingolipid metabolism in male BALB/c mice.
Tsunoda M; Sharma RP; Riley RT
J Biochem Mol Toxicol; 1998; 12(5):281-9. PubMed ID: 9664234
[TBL] [Abstract][Full Text] [Related]
10. Chronic toxicity of fumonisins in turkeys.
Tardieu D; Bailly JD; Skiba F; Métayer JP; Grosjean F; Guerre P
Poult Sci; 2007 Sep; 86(9):1887-93. PubMed ID: 17704375
[TBL] [Abstract][Full Text] [Related]
11. Strong Alterations in the Sphingolipid Profile of Chickens Fed a Dose of Fumonisins Considered Safe.
Tardieu D; Matard-Mann M; Collén PN; Guerre P
Toxins (Basel); 2021 Oct; 13(11):. PubMed ID: 34822554
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1.
Soriano JM; González L; Catalá AI
Prog Lipid Res; 2005 Nov; 44(6):345-56. PubMed ID: 16266752
[TBL] [Abstract][Full Text] [Related]
13. Ceramide synthase inhibition by fumonisin B1 treatment activates sphingolipid-metabolizing systems in mouse liver.
He Q; Suzuki H; Sharma N; Sharma RP
Toxicol Sci; 2006 Dec; 94(2):388-97. PubMed ID: 16960033
[TBL] [Abstract][Full Text] [Related]
14. Fumonisin B1, B2 and B3 in Muscle and Liver of Broiler Chickens and Turkey Poults Fed with Diets Containing Fusariotoxins at the EU Maximum Tolerable Level.
Tardieu D; Travel A; Metayer JP; Le Bourhis C; Guerre P
Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31614665
[TBL] [Abstract][Full Text] [Related]
15. Alteration of tissue and serum sphinganine to sphingosine ratio: an early biomarker of exposure to fumonisin-containing feeds in pigs.
Riley RT; An NH; Showker JL; Yoo HS; Norred WP; Chamberlain WJ; Wang E; Merrill AH; Motelin G; Beasley VR
Toxicol Appl Pharmacol; 1993 Jan; 118(1):105-12. PubMed ID: 8430417
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of sphingolipid synthesis modulate interferon (IFN)-gamma-induced intercellular adhesion molecule (ICAM)-1 and human leukocyte antigen (HLA)-DR expression on cultured normal human keratinocytes: possible involvement of ceramide in biologic action of IFN-gamma.
Wakita H; Nishimura K; Tokura Y; Furukawa F; Takigawa M
J Invest Dermatol; 1996 Sep; 107(3):336-42. PubMed ID: 8751967
[TBL] [Abstract][Full Text] [Related]
17. Increases in serum sphingosine and sphinganine and decreases in complex sphingolipids in ponies given feed containing fumonisins, mycotoxins produced by Fusarium moniliforme.
Wang E; Ross PF; Wilson TM; Riley RT; Merrill AH
J Nutr; 1992 Aug; 122(8):1706-16. PubMed ID: 1640265
[TBL] [Abstract][Full Text] [Related]
18. Comparative effects of fumonisins on sphingolipid metabolism and toxicity in ducks and turkeys.
Benlasher E; Geng X; Nguyen NT; Tardieu D; Bailly JD; Auvergne A; Guerre P
Avian Dis; 2012 Mar; 56(1):120-7. PubMed ID: 22545537
[TBL] [Abstract][Full Text] [Related]
19. Fumonisin B1 induces apoptosis in cultured human keratinocytes through sphinganine accumulation and ceramide depletion.
Tolleson WH; Couch LH; Melchior WB; Jenkins GR; Muskhelishvili M; Muskhelishvili L; McGarrity LJ; Domon O; Morris SM; Howard PC
Int J Oncol; 1999 May; 14(5):833-43. PubMed ID: 10200332
[TBL] [Abstract][Full Text] [Related]
20. In vivo effects of fumonisin B1-producing and fumonisin B1-nonproducing Fusarium moniliforme isolates are similar: fumonisins B2 and B3 cause hepato- and nephrotoxicity in rats.
Voss KA; Plattner RD; Riley RT; Meredith FI; Norred WP
Mycopathologia; 1998; 141(1):45-58. PubMed ID: 9725030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]